Sign in

CIK 0001598646

  • Non-accelerated filer
  • Smaller reporting company

Minerva Neurosciences, Inc.

Sign in to watch
Ticker
NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
260784194
Phone
+1 617-600-7373
Business address
1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale 10% owner sold 22,918 shares at an average $6.02 ($137,896)
  3. 4 Open-market sale 10% owner sold 134,828 shares at an average $6.66 ($898,161)
  4. 4 Open-market buy Director bought 2,000 shares at $6.50 ($13,000)
  5. 4 Open-market sale EVP, CFO & CBO sold 5,999 shares at $7.46 ($44,753)
  6. 4 Open-market sale SVP, Chief Accounting Officer sold 1,559 shares at $7.46 ($11,630)
  7. 4 Open-market sale CEO sold 2,604 shares at $7.46 ($19,426)
  8. 4 Open-market sale SVP & Chief Operating Officer sold 2,728 shares at $7.46 ($20,351)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale President sold 3,117 shares at $7.96 ($24,811)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 6,000 shares at an average $7.97 ($47,800)
  18. 4 Open-market buy Director bought 2,000 shares at $8.20 ($16,400)
  19. 4 Open-market buy Director bought 600 shares at $10.00 ($6,000)
  20. 4 Open-market sale SVP & Chief Operating Officer sold 25,000 shares at an average $12.06 ($301,520)

Page 7 of 14 · 264 filings